[
1. Freed LA, Benjamin EJ, Levy D, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. Journal of the American College of Cardiology 2002; 40: 1298-304.10.1016/S0735-1097(02)02161-7
]Search in Google Scholar
[
2. Zemtsovsky, E.V., Malev, E.G. (2012). Small heart anomalies and dysplastic phenotypes. SPb Russia: Publishing house “ИВЭСЭП”.
]Search in Google Scholar
[
3. Levine RA, Hagége AA, Judge DP, et al. Mitral valve disease - morphology and mechanisms//Nat Rev Cardiol 2015 Dec; 12(12): 689-710.10.1038/nrcardio.2015.161
]Search in Google Scholar
[
4. Bonow RO, Carabello BA, Chatterjee K, et al. R.O. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 52: e1-142.
]Search in Google Scholar
[
5. Stoddard MF, Prince CR, Dillon S, et al. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Col Cardiol 1995; 25(3): 693-699.10.1016/0735-1097(94)00408-I
]Search in Google Scholar
[
6. Basso C, Marra MP, Rizzo S, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation 2015; DOI: 10.1161/CIRCULATIONAHA.115.016291.10.1161/CIRCULATIONAHA.115.016291
]Search in Google Scholar
[
7. Narayanan K, Uy-Evanado A, Teodorescu C, et al. Mitral Valve Prolapse and Sudden Cardiac Arrest in the Community. Heart Rhythm 2016; 13(2): 498-503.10.1016/j.hrthm.2015.09.026
]Search in Google Scholar
[
8. Zeana CD. Recent data on mitral valve prolapse and magnesium deficit. Magnes-Res 1998; 1(3-4): 203-11.
]Search in Google Scholar
[
9. Svanishvili T. Degree of correlation between cardiac auscultatory and echocardiographic findings among young athletes. European Heart Journal 2013; 34 (Suppl. 1): 5773.10.1093/eurheartj/eht310.P5773
]Search in Google Scholar
[
10. Wayne, A.M. (2003). Vegetative disorders: clinic, diagnosis, treatment. M Russia: Medical Information Agency.
]Search in Google Scholar
[
11. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability. Standards of Measurement, Physiological Interpretation and Clinical Use. Circulation 1996; 93: 1043-1065.
]Search in Google Scholar
[
12. Baevsky, R.M., Kirillov, O.I., Kletskin, S.Z. (1984). Mathematical analysis of cardiac rhythm changes under stress. M: Russia.
]Search in Google Scholar
[
13. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2438-2488.10.1016/j.jacc.2014.02.537
]Search in Google Scholar
[
14. Gromova O. Molecular mechanisms of magnesium action on connective tissue dysplasia. Dysplasia of connective tissue 2008; 1: 23-32.
]Search in Google Scholar
[
15. Bobkowski W, Nowak A, Durlach J. The importance of magnesium status in the pathophysiology of mitral valve prolapse. Z Magnes Res 2005; 18(l): 35-52.
]Search in Google Scholar
[
16. Lichodziejewska B, Klos J, Rezler J. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Amer J Cardiol 2007; 79(6): 768-772.10.1016/S0002-9149(96)00865-X
]Search in Google Scholar
[
17. Delling FN, Vasan RS. Epidemiology and Pathophysiology of Mitral Valve Prolapse: New Insights into Disease Progression, Genetics, and Molecular Basis. Circulation 2014; 129(21): 2158-2170.10.1161/CIRCULATIONAHA.113.006702405275124867995
]Search in Google Scholar
[
18. Malpas SC. Neural influeces on cardiovascular variability: possibilities and pitfalls. Amer Physiol Soc 2002; 282(1): 6-20.
]Search in Google Scholar
[
19. Bigger JT Identification of patients high risk for sudden cardiac death. Am J Cardiol 1992; 54(14): 3-8.
]Search in Google Scholar
[
20. Abdullaev RF, Relfgat EB, Babayev ZM. Heart rate disturbances and QT interval changes in the mitral valve prolapse syndrome. Cardiology 1991; 12: 74-76.
]Search in Google Scholar
[
21. Kupriyanova OO, Domnitskaya TM, Domnitsky MV, Dyachenko AV. Clinical significance of magnesium orotate application in adolescents with dysplasia of connective tissue of the heart. Cardiology 2005; 3:76-78.
]Search in Google Scholar
[
22. Völger K.D., Mutschler E. Magnesium - ein überschätztes oder unterbewertetes Pharmakon? // Deutsche Apotheker Zeitung 1991; 13: 589-598.
]Search in Google Scholar
[
23. Martynov AI, Akatova EV. Fifteen years experience of the use of magnesium preparations in patients with mitral valve prolapse. Kardiologiia 2011; 51(6): 60-5.
]Search in Google Scholar
[
24. Amoozgar H, Rafizadeh H, Ajami G, Borzoee M. The Prevalence of Hypomagnesaemia in Pediatric Patients with Mitral Valve Prolapse Syndrome and the Effect of Mg Therapy. Int Cardiovasc Res J 2012; 6(3): 92-95.
]Search in Google Scholar
[
25. Spielberger CD, Gorsuch RL, Lushene R. Manual for State-Trait Anxiety Inventory. Consulting Psychologist Press, California, USA, 1970
]Search in Google Scholar
[
26. Khanin ro..H. Khanin Yu.L. Quick guide for the use of the scale of reactive and personal anxiety of Spielberg. Leningrad, Leningrad Institute of Physical Culture, 1976. P. 18 (in Russian).
]Search in Google Scholar
